Rolf Luft Research Grants

Rolf Luft Research Grants 2017

Applications were evaluated externally. Decision on grants was taken at the end of 2017 by SRP Diabetes management. Many excellent proposals were received and the following researchers were selected in stiff competition:

ROLF LUFT GRANTS FOR BASIC RESEARCH

Olov Andersson, Department of Cell and Molecular Biology

Myriam Aouadi, ICMC, Department of Medicine Huddinge

Niklas Björkström, Department of Medicine Huddinge

Christian Broberger, Department of Neuroscience

Carsten Daub, Department of Biosciences and Nutrition

Johanna Lanner, Department of Physiology and Pharmacology

Jurga Laurencikiene, Department of Medicine Huddinge

Volker Lauschke, Department of Physiology and Pharmacology

Jorge Ruas, Department of Physiology and Pharmacology

Kirsty Spalding, Department of Cell and Molecular Biology/ICMC

Elisabet Stener-Victorin, Department of Physiology and Pharmacology

ROLF LUFT GRANTS FOR CLINICAL RESEARCH

Daniel P Andersson, Department of Medicine Huddinge

Sergiu-Bogdan Catrina, Department of Molecular Medicine and Surgery

Torbjörn Lundgren, Department of Clinical Science, Intervention and Technology

 

Rolf Luft Research Grants 2015

SRP Diabetes management received many good research proposals and it was thus in hard competition the following applicants were awarded in the 2015 call:

ROLF LUFT GRANTS FOR BASIC RESEARCH

Olov Andersson, Department of Cell and Molecular Biology

Myriam Aouadi, ICMC, Department of Medicine Huddinge

Christian Broberger, Department of Neuroscience

Alexander Chibalin (and info below), Department of Molecular Medicine and Surgery

Jurga Laurencikiene, Department of Medicine Huddinge

Jorge Ruas, Department of Physiology and Pharmacology

Elisabet Stener-Victorin, Department of Physiology and Pharmacology

ROLF LUFT GRANTS FOR CLINICAL RESEARCH

Sergiu-Bogdan Catrina, Department of Molecular Medicine and Surgery

Ingrid Dahlman (and info below), Department of Medicine Huddinge

Rolf Luft Research Grants 2012

John Axelsson received his PhD at Stockholm University in 2005 in the field of psychology with Professor Torbjörn Åkerstedt as supervisor. He started postdoctoral studies at Karolinska Institutet, Dept of Clinical Neuroscience, in 2006 where he continued studies on sleep deprivation. The findings that sleep and testosterone are crucial for tolerance, led Dr Axelsson to perform studies on sleep, hormone regulation and metabolism. His present research is carried out within psychoneuroimmunology - an interdisciplinary research field combining several disciplines - e.g. psychology, neurology, endocrinology and immunology - to increase the understanding how these systems interact in health and disease. Dr. Axelsson collaborates with Professor Kerstin Brismar on how sleep affects the development and severity of metabolic disturbances, such as diabetes, and possible impact of sleep on preventions and treatments. Since 2009 he is an Associate Professor at Dept of Clinical Neuroscience, Karolinska Institutet.

 

Lektor

John Axelsson

Telefon:08-524 824 61

Enhet:Psykologi Axelsson

E-post:John.Axelsson@ki.se

 

Alexander Chibalin received his PhD 1993 at University of Lausanne, Switzerland, under the supervision of Professor Käthi Geering concerning regulation of Na,K-ATPase activity by protein kinases. In 1994 he moved into the diabetes field by starting a postdoc at Karolinska Institutet with Professor Per-Olof Berggren, further investigating the regulation of Na,K-ATPase and suphonylurea binding proteins in pancreatic β-cells. In 1997 he took up a Research Assistantship in the group of Harriet Wallberg-Henriksson where he developed an independent line of research concerning the regulation of ion and glucose transporters in skeletal muscle. Dr. Chibalin has also studied regulation of energy homeostasis in healthy versus metabolically altered states. In collaboration with Professor Juleen Zierath, he revealed a previously unrecognized role for diacylglycerol kinase δ (DGKδ) in contributing to hyperglycemia-induced peripheral insulin resistance and thereby exacerbating the severity of Type 2 diabetes. Since 2003 he is an Associate Professor in the section of Integrative Physiology, Dept of Molecular Medicine and Surgery.

 

Forskare

Alexander Chibalin

Telefon:08-524 875 12

Enhet:Integrativ fysiologi

E-post:Alexander.Chibalin@ki.se

 

Ingrid Dahlman completed her MD at the Karolinska Institute in 1996, and in 1999 defended her thesis on genetic regulation of experimental autoimmne neuroinflammatory diseases in the laboratory of Professor Tomas Olsson. During her thesis work Ingrid became interested in human genetics and in 2001 she did a post doc in Professor John A Todd’s laboratory in Cambridge working on genetics of type 1 diabetes. Since returning to Stockholm, Ingrid has been employed at the Department of Endocrinology at the Karolinska university hospital in Huddinge and affiliated with the Lipid laboratory headed by professor Peter Arner. Ingrid became Associate professor in 2005, and Consultant in Endocrinology in 2007. In 2010 she attained a part-time senior research position financed by the Swedish Research council. Ingrid’s current research is focused on the role of human adipose tissue in development of obesity associated insulin resistance. More precisely, she applies global transcriptomic analyses and other pangenomic approaches to identify new mediators and regulators of insulin resistance in human fat cells.

 

Anställd

Ingrid Dahlman

Telefon:08-524 834 66

Enhet:Enheten för endokrinologi och diabetes

E-post:Ingrid.Dahlman@ki.se

 

Malin Flodström Tullberg was recruited to Karolinska Institutet in 2003. She defended her Ph.D. thesis in Medical Cell Biology at Uppsala University, Sweden, in 1998. During the years 1998 – 2003 she was a postdoctoral fellow in immunology and virology at The Scripps Research Institute, La Jolla, USA. Malin’s main research interest is the etiopathogenesis of type 1 diabetes. The research in her laboratory focuses on the cross-talk between the pancreatic beta cell, the immune system and a type of viruses that have been associated with diabetes development in humans. The research group also has an interest in the etiology of cystic fibrosis-related diabetes and, together with the group of Dr. Annika Tibell, actively participates in research focusing on the development of methods to prevent pancreatic islet rejection. All studies are performed with a translational approach and combine basic mechanistic in vitro studies in cell lines and pancreatic islets from humans, with pathophysiological studies in human tissue samples and in vivo model systems. Since 2005 she is an Associate Professor at Dept of Medicine, Huddinge.

 

Professor

Malin Flodström Tullberg

Telefon:046-852487625

Enhet:Centrum för infektionsmedicin

E-post:Malin.Flodstrom-Tullberg@ki.se